We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Medlab Middle East 2025 Opens with Groundbreaking Innovations

By LabMedica International staff writers
Posted on 03 Feb 2025
Print article
Image: Medlab Middle East features over 800 exhibitors from 40 countries along with 20,000 attendees (Photo courtesy of Informa Markets)
Image: Medlab Middle East features over 800 exhibitors from 40 countries along with 20,000 attendees (Photo courtesy of Informa Markets)

The 24th edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, is being held at Dubai World Trade Centre from 3-6 February. Organized by Informa Markets (London, UK), the event themed ‘Empowering today’s medical labs for tomorrow’s future’ features over 800 exhibitors from 40 countries, with 20,000 visitors exploring the latest technology and updates for the laboratory industry. Medlab Middle East showcases the latest innovations and technologies across eight dynamic product categories, which include disposables and consumer goods, emergency medicine, imaging and diagnostics, healthcare and general services, IT, laboratory, medical equipment and devices, and pharma and nutrition.

The 24th edition builds on the success of Medlab Middle East 2024 when the event generated an estimated business value of USD 670 million, fueling medical laboratory growth across the Middle East and beyond. The event features the most prominent names in the industry, with key exhibitors showcasing their innovations including Snibe, PureLab, World Data Exchange, Merck and Abbott. The world’s only multidisciplinary congress in the medical laboratory industry, the Medlab Middle East Congress returns with 12 CME-accredited conferences in Lab Management, Clinical Chemistry, Lab Quality, Hematology, Clinical Microbiology, Molecular Diagnostics, Blood Transfusion Medicine and Cellular Therapy, Histopathology, Lab Sustainability and Immunology. A new Lab Automation conference debuts this year, designed to explore the transformative impact of automation and IT workflows on laboratory operations.

The Congress features 150 local and international speakers and 60 VIP guests and is expected to draw over 4,000 delegates from the medical and laboratory fields. Key topics explored at the event include ‘The role of laboratory leadership to prepare laboratories for outbreak detection’, ‘Advances in stem cell therapy’ and ‘The past and the future for biomedical sciences and career options for the next generation’. Medlab Middle East 2025 is introducing two new leadership forums dedicated to women’s health and precision medicine. The Women’s Health Leadership Forum, held on the opening day of Medlab Middle East, aims to enhance women’s health through laboratory diagnostics. The event showcases cutting-edge innovations, addresses key challenges and uncovers collaboration opportunities that will enhance diagnostic capabilities for addressing women’s health needs.

The Precision Medicine Leadership Forum, featuring precision medicine experts, aims to offer insights from top experts in precision medicine, fostering a dialogue around cutting-edge innovations in genetics, personalized healthcare and new targeted therapies shaping the future of patient care. The program includes sessions on how genetic data is being integrated into treatment plans and the impact of precision medicine on improving patient care, among several other key topics in the precision medicine field. Also new for the 2025 edition, the Global Lab Leaders Breakfast Forum unites Medlab portfolio global advisers, scientific chairs, international partners and stakeholders in an exclusive, invitation-only dialogue, concentrating on topics that are crucial to advancing laboratory practices worldwide. The GCC Lab Leaders Breakfast Forum will see a gathering of officials, experts, and specialists from both public and private sector laboratories, as well as national standardization bodies across the GCC region. The event aims to foster collaboration and open dialogue on critical topics, including laboratory management, quality assurance, and proficiency testing. The ABCHealth Session at Medlab Middle East explores the transformative role of AI and advanced technologies in reshaping diagnostic business models across Africa.

“The 2025 edition of Medlab Middle East promises to be a landmark event which spotlights cutting-edge advancements and sustainable practices in laboratory medicine,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “The event offers a unique opportunity to connect with a diverse range of companies and professionals in the medical laboratory industry, opening doors to new networks and opportunities for growth.”

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.